0
0
0
Increasing Medication Access for Seniors Act of 2024
12/19/2024, 9:06 AM
Summary of Bill HR 8725
Bill 118 hr 8725, also known as the Increasing Medication Access for Seniors Act of 2024, aims to improve access to affordable prescription medications for senior citizens in the United States. The bill was introduced in the House of Representatives in response to concerns about rising drug prices and the financial burden this places on older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
Current Status of Bill HR 8725
Bill HR 8725 is currently in the status of Bill Introduced since June 13, 2024. Bill HR 8725 was introduced during Congress 118 and was introduced to the House on June 13, 2024. Bill HR 8725's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024
Bipartisan Support of Bill HR 8725
Total Number of Sponsors
2Democrat Sponsors
2Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 8725
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 8725
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
Comments
Sponsors and Cosponsors of HR 8725
Latest Bills
Childhood Diabetes Reduction Act of 2026
Bill S 5026August 26, 2026
Making America's Food Safer Act
Bill S 4974August 26, 2026
PEARL Act
Bill S 4079August 26, 2026
Yuhaaviatam of San Manuel Nation Land Exchange Act
Bill HR 3925August 25, 2026
To provide for the equitable settlement of certain Indian land disputes regarding land in Illinois, and for other purposes.
Bill HR 2827August 25, 2026
Local Communities & Bird Habitat Stewardship Act of 2026
Bill HR 3276August 25, 2026
No Antisemitism in Education Act of 2026
Bill HR 8476August 25, 2026
National Law Enforcement Officers Remembrance, Support, and Community Outreach Act
Bill HR 309August 25, 2026
Promoting Resilient Buildings Act
Bill S 388August 25, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784August 24, 2026


